These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11182753)

  • 1. Loss of heterozygosity at the mannose 6-phosphate/insulin-like growth factor 2 receptor locus: a frequent but late event in adrenocortical tumorigenesis.
    Leboulleux S; Gaston V; Boulle N; Le Bouc Y; Gicquel C
    Eur J Endocrinol; 2001 Feb; 144(2):163-8. PubMed ID: 11182753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor (M6P/IGF2R) locus predisposes patients to radiation-induced lung injury.
    Kong FM; Anscher MS; Sporn TA; Washington MK; Clough R; Barcellos-Hoff MH; Jirtle RL
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):35-41. PubMed ID: 11163495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R), a putative breast tumor suppressor gene.
    Oates AJ; Schumaker LM; Jenkins SB; Pearce AA; DaCosta SA; Arun B; Ellis MJ
    Breast Cancer Res Treat; 1998 Feb; 47(3):269-81. PubMed ID: 9516081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M6P/IGF2R is mutated in squamous cell carcinoma of the lung.
    Kong FM; Anscher MS; Washington MK; Killian JK; Jirtle RL
    Oncogene; 2000 Mar; 19(12):1572-8. PubMed ID: 10734317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers.
    Devi GR; De Souza AT; Byrd JC; Jirtle RL; MacDonald RG
    Cancer Res; 1999 Sep; 59(17):4314-9. PubMed ID: 10485478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors.
    Gicquel C; Bertagna X; Schneid H; Francillard-Leblond M; Luton JP; Girard F; Le Bouc Y
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1444-53. PubMed ID: 7911125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity of M6P/IGF2R gene is an early event in the development of prostate cancer.
    Hu CK; McCall S; Madden J; Huang H; Clough R; Jirtle RL; Anscher MS
    Prostate Cancer Prostatic Dis; 2006; 9(1):62-7. PubMed ID: 16304558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors.
    Gicquel C; Raffin-Sanson ML; Gaston V; Bertagna X; Plouin PF; Schlumberger M; Louvel A; Luton JP; Le Bouc Y
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2559-65. PubMed ID: 9253334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic changes and expression of the mannose 6-phosphate/insulin-like growth factor II receptor gene in human hepatitis B virus-associated hepatocellular carcinoma.
    Yang EB; Qin LL; Zhao YN; Zhang K; Chow P
    Int J Mol Med; 2003 Jun; 11(6):773-8. PubMed ID: 12736721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of insulin-like growth factor II (IGF-II)-dependent cell growth by multidentate pentamannosyl 6-phosphate-based ligands targeting the mannose 6-phosphate/IGF-II receptor.
    Zavorka ME; Connelly CM; Grosely R; MacDonald RG
    Oncotarget; 2016 Sep; 7(38):62386-62410. PubMed ID: 27694692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity of the mannose 6-phosphate/insulin-like growth factor II receptor and p53 genes in human hepatocellular carcinoma.
    Kishimoto Y; Morisawa T; Kitano M; Shiota G; Horie Y; Suou T; Ito H; Kawasaki H; Hasegawa J
    Hepatol Res; 2001 May; 20(1):68-83. PubMed ID: 11282487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M6P/IGF2R loss of heterozygosity in head and neck cancer associated with poor patient prognosis.
    Jamieson TA; Brizel DM; Killian JK; Oka Y; Jang HS; Fu X; Clough RW; Vollmer RT; Anscher MS; Jirtle RL
    BMC Cancer; 2003 Feb; 3():4. PubMed ID: 12589712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M6P/IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan.
    Oka Y; Waterland RA; Killian JK; Nolan CM; Jang HS; Tohara K; Sakaguchi S; Yao T; Iwashita A; Yata Y; Takahara T; Sato S; Suzuki K; Masuda T; Jirtle RL
    Hepatology; 2002 May; 35(5):1153-63. PubMed ID: 11981765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. M6P/IGF2 receptor: a candidate breast tumor suppressor gene.
    Hankins GR; De Souza AT; Bentley RC; Patel MR; Marks JR; Iglehart JD; Jirtle RL
    Oncogene; 1996 May; 12(9):2003-9. PubMed ID: 8649861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors.
    Gicquel C; Bertagna X; Gaston V; Coste J; Louvel A; Baudin E; Bertherat J; Chapuis Y; Duclos JM; Schlumberger M; Plouin PF; Luton JP; Le Bouc Y
    Cancer Res; 2001 Sep; 61(18):6762-7. PubMed ID: 11559548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of insulin-like growth factor 2 and its receptors in human tumors.
    Pavelic K; Buković D; Pavelić J
    Mol Med; 2002 Dec; 8(12):771-80. PubMed ID: 12606812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imprint status of M6P/IGF2R and IGF2 in chickens.
    Nolan CM; Killian JK; Petitte JN; Jirtle RL
    Dev Genes Evol; 2001 Apr; 211(4):179-83. PubMed ID: 11455432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors.
    De Souza AT; Hankins GR; Washington MK; Fine RL; Orton TC; Jirtle RL
    Oncogene; 1995 May; 10(9):1725-9. PubMed ID: 7753549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common polymorphism in exon 40 of the human mannose 6-phosphate/insulin-like growth factor II receptor gene.
    Zhong X; Hemmi H; Shimatake H
    Mol Cell Probes; 1999 Oct; 13(5):397-400. PubMed ID: 10508563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 are associated with malignancy in sporadic adrenocortical tumors.
    Boulle N; Logié A; Gicquel C; Perin L; Le Bouc Y
    J Clin Endocrinol Metab; 1998 May; 83(5):1713-20. PubMed ID: 9589681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.